E. Willemse

Institut Jules Bordet

Papers

1

Total Citations

2

H-Index

1

About

E. Willemse is a clinical researcher specializing in head and neck oncology, with a focus on optimizing treatment strategies for oropharyngeal, supraglottic, and hypopharyngeal carcinomas. Their most notable contribution is the design and leadership of the Phase III study comparing the "best of" radiotherapy against the "best of" trans-oral surgery (TOS) for patients with T1-T2, N0-N1 tumors—a landmark trial that directly addresses the long-standing debate between surgical and non-surgical approaches in early-stage disease. This work, published in 2022, has garnered 2 citations and represents a critical step toward personalized, evidence-based decision-making in head and neck cancer care. Willemse’s research bridges the gap between clinical equipoise and practical outcomes, offering clarity for multidisciplinary teams. Their dedication to rigorous comparative effectiveness research underscores a commitment to improving survival and quality of life for patients with these challenging malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
706TiP Phase III study assessing the “best of” radiotherapy compared to the “best of” surgery (trans-oral surgery (TOS)) in patients with T1-T2, N0-N1 oropharyngeal, supraglottic carcinoma and with T1, N0 hypopharyngeal carcinoma
2 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Institut Jules Bordet

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago